Concepedia

Andreas Josting

AJ

59

Publications

4.9K

Citations

35

H-Index

1995

Active since

Affiliations

University Hospital Cologne(Current)

University of Cologne

German Inflammatory Bowel Diseases Study Group

Ludwig-Maximilians-Universität München

Carl-Thiem-Klinikum Cottbus

Andreas Josting is an author at University Hospital Cologne specializing in medicine, oncology, and radiation oncology.

Top concepts

Publications per year

1995–2013

59

Publications

59

Involved-Field Radiotherapy Is Equally Effective and Less Toxic Compared With Extended-Field Radiotherapy After Four Cycles of Chemotherapy in Patients With Early-Stage Unfavorable Hodgkin’s Lymphoma: Results of the HD8 Trial of the German Hodgkin’s Lymphoma Study Group

Andreas Engert, Petra Schiller, Andreas Josting et al. · Journal of Clinical Oncology · 2003 · 456 citations

New Prognostic Score Based on Treatment Outcome of Patients With Relapsed Hodgkin's Lymphoma Registered in the Database of the German Hodgkin's Lymphoma Study Group

Andreas Josting · Journal of Clinical Oncology · 2002 · 272 citations

Time-intensified dexamethasone/cisplatin/cytarabine:an effective salvage therapy with low toxicity in patients with relapsed and refractory Hodgkin’s disease

Andreas Josting, Christian Rudolph, Marcel Reiser et al. · Annals of Oncology · 2002 · 219 citations · Full text

, , +7

Fludarabine in Combination With Alemtuzumab Is Effective and Feasible in Patients With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia: Results of a Phase II Trial

Thomas Elter, Peter Borchmann, H. Schulz et al. · Journal of Clinical Oncology · 2005 · 212 citations

Prognostic factors and treatment outcome in primary progressive Hodgkin lymphoma: a report from the German Hodgkin Lymphoma Study Group

Andreas Josting, U. Rueffer, Jeremy Franklin et al. · Blood · 2000 · 207 citations · Full text

Rows per page

1–5 of 59